-
This video talks about Michigan, but it’s alive and well in California as well with a very limited number of physicians that see Medicaid (MediCal) patients. We see millions spent on research, but what good is all the research if there are not enough individuals to have access. BD With...
-
The HER2 gene mutation is best known for the test for breast cancer and now the mutations are proving to show some target relief with treating gastric cancer. The study is finding that a combination targeted treatment with 2 drugs is having success. Research is showing that all gastric cancer...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
03-03-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, health insurance, Cancer, Oncology, Breast Cancer, United HealthCare, Therapy, UCLA Jonsson Cancer Center, reasearch and development, gastric cancer, targets, herception, Tykerb, HER2
-
This is a beginning groundwork for a commercial test. This could also lead to tests for other types of cancer, such as prostate and kidney cancer. This is similar to the breast cancer study for inherited genes in short. Pancreas cancer is so deadly and with having information up front...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-11-2010
Filed under:
Filed under: Medically Related, Technology, personalized medicine, DNA, Genomics, healthcare, Cancer, Research and Development, Translational Medicine, UCLA Jonsson Cancer Center, Pancreas Cancer
-
Once again the drive and race for data is on the move, insurers will fall over themselves 10 times over to get a hold of data to analyze. I agree with the comments from the Komen Foundation, an insurance company should not be doing this type of evaluation, it’s easy to be a Monday morning quarterback...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-09-2010
Filed under:
Filed under: Medically Related, Insurance, My Commentaries, health insurance, Claims, Cancer, Oncology, Breast Cancer, Roche, United HealthCare, healthcare reform, Susan G. Komen, Avastic
-
Last December Teva announced they were going to ask so now it looks like the FDA has given the ok to review. Due to lack of whatever you want to call it these days in Congress, there are no provisions where a generic version of a biotech drug (aka biosimilars) can be approved and the drug is viewed...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-02-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Generic Drugs, Congress, Merck, Politics, Amgen, Intellectual property, Teva, Drug approvals, drugs discounts, biosimilar
-
Say hello to Dr. Michael Benjamin, an oncologist from the blogging community from InteractMD.com who practices in southern California. Today we have his take on all the warnings coming out relative to treatments for prostate cancer. He’s been a long time reader and follower...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
02-02-2010
Filed under:
Filed under: Medically Related, Other Items of Interest, healthcare, Cardiology, Cancer, Oncology, Blogging, hormones, video blogging, Michael Benjamin, InteractMD, straight talk
-
This is quite a tragic story about 2 specific individuals that were over dosed with radiation treatment. Now there are emerging stories in California about over exposure during brains cancer scans, over 200 patients, but their times of exposure were less than these 2 individuals here who were getting...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-25-2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Education, Cancer, Heatlh IT, software, Heatlhcare, Safety, Algorithms, New York, Treatment plans, Varian System, accountability, radation treatment
-
Quest is the first lab to offer the laboratory test based on the Septin9 marker. The test is called the “ColoVantage” test and is not considered a screening test but patients may consider the test as it is less evasive than some of the current tests. In other related Quest news, one of their...
-
The molecular lab test was approved by the FDA in 2007 to detect breast cancer spreading to the lymph nodes. The test could be beneficial at the time of surgery to determine if additional lymph nodes should be removed instead of having a second surgical procedure. The clinical...
-
I have been writing about this for a while now, but I wonder why can’t we get some numbers crunched here? We keep hearing about the Bio Identical hormone treatments that are customized, but why can’t we get some numbers that compare “FDA Approved” Bio identical hormones compared to Premarin? ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-08-2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Diet, NIH, Harvard, HRT, Oprah, estrogen, wellness, hormone replacement therapytherapy, Woman's Heatlh, bio identical hormones, Premarin, Dr. Erika, Erika Schwartz, Women's Health Initiative
-
The article states that Merck , one of the heavy cash companies around today is looking at expanding their horizons with acquisitions that fit the mold, perhaps smaller companies and not the larger biotechs. Just recently I read where Merck in the cash line was only behind Pfizer who was slated...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-28-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Cancer, Merck, Research and Development, chemicals, Erbitux, acquisitions
-
The video makes reference not only to websites but also devices to be aware of. Below are a few recent links that have been posted here. Pair indicted on fraud charges in medical-device probe California Doctor Arrested on Fraud Charges of Curing Cancer One that received a lot of news...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-28-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, Video, healthcare, Medical Devices, Cancer, FDA, Internet, Fraud, websites, H1N1, CURES
-
If you have kept up with the news of late, you may have read quite a bit about this issue and where the disputes lie. It all goes back to the women's health initiative and the fact that ghostwriting was used to promote the drug. Under the related reading section below I have a few posts...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-17-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Wyeth, Pfizer, Lawsuits, HRT, Insurance companies, Premarin, Women's Health Initiative, ghostwriters, Dr. Erika Schwartz, Bioidentical HRT, menopause
-
Now that the code has been “cracked” this will lead to the creation of drugs that will be able to target these areas, and maybe even a cure. This is truly big news as the 2 of the most deadly types of cancer have been identified for targeting. A blood test will be able to help diagnose in...
-
Since May 2008, SU2C has raised more than $100 million from a wide range of philanthropic, corporate, and organizational donors, as well as the general public. Watch the video below for additional details on how the grants were unlike most in the fact that the scientists were able to take on risk...